Cargando…

Treatment-Emergent Neuroendocrine Prostate Cancer: A Clinicopathological and Immunohistochemical Analysis of 94 Cases

PURPOSE: This study aimed to evaluate the pathological characteristics, immunophenotype, and prognosis of treatment-emergent neuroendocrine prostate cancer (T-NEPC). MATERIALS AND METHODS: We collected 231 repeated biopsy specimens of castration-resistant prostate cancer (CRPC) cases between 2008 an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Qingfu, Han, Yunan, Zhang, Yao, Liu, Dan, Ming, Jian, Huang, Bo, Qiu, Xueshan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882702/ https://www.ncbi.nlm.nih.gov/pubmed/33598420 http://dx.doi.org/10.3389/fonc.2020.571308

Ejemplares similares

Primary micro neuroendocrine tumor arising in a horseshoe kidney with cyst: report of a case and review of literature
por: Zhang, Qingfu, et al.
Publicado: (2012)

Neuroendocrine carcinoma of the esophagus: Clinicopathological and immunohistochemical features of 14 cases
por: Egashira, Akinori, et al.
Publicado: (2017)

Clinicopathological and immunological profiles of prostate adenocarcinoma and neuroendocrine prostate cancer
por: Huang, Gang, et al.
Publicado: (2022)

Establishment and validation of a clinicopathological prognosis model of gastroenteropancreatic neuroendocrine carcinomas
por: Chen, Jing, et al.
Publicado: (2022)

Dedifferentiated Endometrioid Carcinomas with Neuroendocrine Differentiation: A Clinicopathological and Immunohistochemical Study of Three Cases
por: Zhou, Feng, et al.
Publicado: (2020)

Prostate Cancer and Neuroendocrine Differentiation: More Neuronal, Less Endocrine?
por: Grigore, Alexandru Dan, et al.
Publicado: (2015)

Prognostic Significance of Cyclin E1 Expression in Patients With Chordoma: A Clinicopathological and Immunohistochemical Study
por: Wei, Ran, et al.
Publicado: (2020)

Clinicopathological and immunohistochemical study of pulmonary neuroendocrine tumors – A single-institute experience
por: Pasala, Uma Jyothi Swaroopa, et al.
Publicado: (2021)

Neuroendocrine Tumors of the Large Intestine: Clinicopathological Features and Predictive Factors of Lymph Node Metastasis
por: Kojima, Motohiro, et al.
Publicado: (2016)

PD-L1, Mismatch Repair Protein, and NTRK Immunohistochemical Expression in Cervical Small Cell Neuroendocrine Carcinoma
por: Chen, Longyun, et al.
Publicado: (2021)

Clinicopathological and molecular analysis of microsatellite instability in prostate cancer: a multi-institutional study in China
por: Zhang, Huizhi, et al.
Publicado: (2023)

Neuroendocrine Differentiation in Prostate Cancer: A Mechanism of Radioresistance and Treatment Failure
por: Hu, Chang-Deng, et al.
Publicado: (2015)

Pulmonary neuroendocrine tumors: study of 266 cases focusing on clinicopathological characteristics, immunophenotype, and prognosis
por: Zhang, Shuwen, et al.
Publicado: (2022)

The Many Faces of Neuroendocrine Differentiation in Prostate Cancer Progression
por: Terry, Stéphane, et al.
Publicado: (2014)

Targeting Neuroendocrine Prostate Cancer: Molecular and Clinical Perspectives
por: Vlachostergios, Panagiotis J., et al.
Publicado: (2015)

Primary neuroendocrine prostate cancer with adrenal gland metastasis
por: Muñoz López, Antonio Yaromin, et al.
Publicado: (2021)

Radiomic signatures based on pretreatment 18F-FDG PET/CT, combined with clinicopathological characteristics, as early prognostic biomarkers among patients with invasive breast cancer
por: Jia, Tongtong, et al.
Publicado: (2023)

Comprehensive analysis of androgen receptor status in prostate cancer with neuroendocrine differentiation
por: Su, Ruopeng, et al.
Publicado: (2022)

Interleukin-7 up-regulates cyclin D1 via activator protein-1 to promote proliferation of cell in lung cancer
por: Ming, Jian, et al.
Publicado: (2011)

High-throughput drug screening identifies fluoxetine as a potential therapeutic agent for neuroendocrine prostate cancer
por: Chen, Lei, et al.
Publicado: (2023)

Prostate sclerosing adenopathy: A clinicopathological and immunohistochemical study of twelve patients
por: Feng, Run-Lin, et al.
Publicado: (2022)

Prognostic value of computed tomography radiomics features in patients with gastric neuroendocrine neoplasm
por: Yang, Zhi-hao, et al.
Publicado: (2023)

Molecular Links Between Angiogenesis and Neuroendocrine Phenotypes in Prostate Cancer Progression
por: Wang, Zheng, et al.
Publicado: (2020)

A rare case of prostate neuroendocrine tumor: A case report
por: Teh, Shunxing, et al.
Publicado: (2022)

Clinicopathological characteristics and survival outcomes in neuroendocrine prostate cancer: A population-based study
por: Zhu, Jiamin, et al.
Publicado: (2021)

Neuroendocrine prostate cancer treated with multimodal examination and therapy: A case report
por: Hara, Midori, et al.
Publicado: (2022)

Clinicopathological significance of the EMT-related proteins and their interrelationships in prostate cancer. An immunohistochemical study
por: Parol-Kulczyk, Martyna, et al.
Publicado: (2021)

Clinicopathological characteristics and prognosis of 77 cases with type 3 gastric neuroendocrine tumours
por: Li, Yuan-Liang, et al.
Publicado: (2020)

In-Hospital Mortality Risk Model of Gastric Cancer Surgery: Analysis of a Nationwide Institutional-Level Database With 94,277 Chinese Patients
por: Wu, Zhouqiao, et al.
Publicado: (2019)

Molecular Chaperone GRP94/GP96 in Cancers: Oncogenesis and Therapeutic Target
por: Duan, Xiaofeng, et al.
Publicado: (2021)

Co-occurrence of Dermatomyositis and Polycythemia Unveiling Rare de Novo Neuroendocrine Prostate Tumor
por: Papagoras, Charalampos, et al.
Publicado: (2018)

Hypercalcemia due to parathyroid hormone-related peptide secreted by neuroendocrine dedifferentiated prostate cancer
por: Ando, Takashi, et al.
Publicado: (2018)

A bibliometric study of the top 100 most-cited papers in neuroendocrine prostate cancer
por: Gan, Yu, et al.
Publicado: (2023)

Pediatric pituitary neuroendocrine tumors–a 13-year experience in a tertiary center
por: Li, Xiaoxu, et al.
Publicado: (2023)

Neoadjuvant therapy in pancreatic neuroendocrine neoplasms: A systematic review and meta-analysis
por: Li, Yongzheng, et al.
Publicado: (2022)

Primary intracranial sarcomas: a clinicopathological investigation
por: Cai, Yu-Xiang, et al.
Publicado: (2023)

Neuroendocrine Carcinoma of the Uterine Cervix: A Clinicopathologic and Immunohistochemical Study with Focus on Novel Markers (Sst2–Sst5)
por: Inzani, Frediano, et al.
Publicado: (2020)

Gross Findings of Widespread Visceral Metastasis of Prostatic Adenocarcinoma With Neuroendocrine Features: A Case Report
por: Habibian, David J., et al.
Publicado: (2016)

Pancreatic metastasis from locally recurrent neuroendocrine differentiated prostate cancer after radical prostatectomy
por: Ando, Takashi, et al.
Publicado: (2020)

Gastric neuroendocrine carcinoma with positive staining for prostate cancer markers including prostate-specific antigen and alpha-methylacyl-CoA racemase
por: Hakozaki, Yuji, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_73ld4msi1moc9be7dcocpnh1mn